FGFs in endochondral skeletal development

Journal of Cellular Biochemistry

Volumn 110, Issue 5, 2010, Pages 1046-1057

  Degnin, Catherine R ^a   Laederich, Melanie B ^a   Horton, William A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Endochondral ossification; FGF; FGFR; Growth plate; Skeletal development

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HEPARAN SULFATE; HEPARIN; IMMUNOGLOBULIN; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; PROTEOGLYCAN; TRANSCRIPTION FACTOR RUNX2;

BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; ENCHONDRAL OSSIFICATION; GENE MUTATION; HUMAN; MORPHOGENESIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARACRINE SIGNALING; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; RICKETS; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; FIBROBLAST GROWTH FACTORS; GROWTH PLATE; HUMANS; MODELS, BIOLOGICAL; OSTEOGENESIS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 77954942508     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22629     Document Type: Review

References (122)

1. Allen BL, Rapraeger AC. 2003. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J Cell Biol 163:637-648.
2. Aszodi A, Hunziker EB, Brakebusch C, Fassler R. 2003. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev 17:2465-2479.
3. Bae JH, Lew ED, Yuzawa S, Tome F, Lax I, Schlessinger J. 2009. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site. Cell 138:514-524.
4. Bai X, Miao D, Goltzman D, Karaplis AC. 2007. Early lethality in Hyp mice with targeted deletion of Pth gene. Endocrinology 148:4974-4983. (Pubitemid 47481537)
5. Beenken A, Mohammadi M. 2009. The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235-253.
6. Belleudi F, Leone L, Maggio M, Torrisi MR. 2009. Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Exp Cell Res 315:2181-2191.
7. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. 2007. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003-4008. (Pubitemid 350224109)
8. Ben-Zvi T, Yayon A, Gertler A, Monsonego-Ornan E. 2006. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling. J Cell Sci 119:380-387. (Pubitemid 43210706)
9. Bottcher RT, Pollet N, Delius H, Niehrs C. 2004. The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat Cell Biol 6:38-44. (Pubitemid 38425728)
10. Bryant DM, Wylie FG, Stow JL. 2005. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol Biol Cell 16:14-23. (Pubitemid 40024286)
11. Bundschu K, Knobeloch KP, Ullrich M, Schinke T, Amling M, Engelhardt CM, Renne T, Walter U, Schuh K. 2005. Gene disruption of Spred-2 causes dwarfism. J Biol Chem 280:28572-28580. (Pubitemid 41105758)
12. Catela C, Bilbao-Cortes D, Slonimsky E, Kratsios P, Rosenthal N, Te Welscher P. 2009. Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice. Dis Model Mech 2:283-294.
13. Chen L, Deng CX. 2005. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci 10:1961-1976. (Pubitemid 40529047)
14. Chen H, Ma J, Li W, Eliseenkova AV, Xu C, Neubert TA, Miller WT, Mohammadi M. 2007. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell 27:717-730. (Pubitemid 47333217)
15. Chen H, Xu CF, Ma J, Eliseenkova AV, Li W, Pollock PM, Pitteloud N, Miller WT, Neubert TA, Mohammadi M. 2008a. A crystallographic snapshot of tyrosine trans-phosphorylation in action. Proc Natl Acad Sci USA 105: 19660-19665.
16. Chen X, Macica CM, Nasiri A, Broadus AE. 2008b. Regulation of articular chondrocyte proliferation and differentiation by indian hedgehog and parathyroid hormone-related protein in mice. Arthritis Rheum 58:3788-3797.
17. Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H. 2001. Regulation of osteoclast differentiation by fibroblast growth factor 2: Stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res 16:2074-2081.
18. Cho JY, Guo C, Torello M, Lunstrum GP, Iwata T, Deng C, Horton WA. 2004. Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc Natl Acad Sci USA 101:609-614.
19. Christensen C, Lauridsen JB, Berezin V, Bock E, Kiselyov VV. 2006. The neural cell adhesion molecule binds to fibroblast growth factor receptor 2. FEBS Lett 580:3386-3390.
20. Chung UI. 2004. Essential role of hypertrophic chondrocytes in endochondral bone development. Endocr J 51:19-24.
21. Colnot C, de la Fuente L, Huang S, Hu D, Lu C, St-Jacques B, Helms JA. 2005. Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development 132:1057-1067.
22. Dailey L, Laplantine E, Priore R, Basilico C. 2003. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161:1053-1066.
23. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16:233-247.
24. de Frutos CA, Vega S, Manzanares M, Flores JM, Huertas H, Martinez-Frias ML, Nieto MA. 2007. Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. Dev Cell 13:872-883.
25. deLapeyriere O, Ollendorff V, Planche J, Ott MO, Pizette S, Coulier F, Birnbaum D. 1993. Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. Development 118:601-611.
26. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149.
27. Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. 1995. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 203:223-240.
28. Francavilla C, Cattaneo P, Berezin V, Bock E, Ami D, de Marco A, Christofori G, Cavallaro U. 2009. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J Cell Biol 187:1101-1116.
29. Fujimori S, Kostanova-Poliakova D, Hartmann C. 2009. Role of growth factors in bone development and differentiation. In: Pourquie O, editor. The skeletal system. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. pp. 219-261.
30. Fukai J, Yokote H, Yamanaka R, Arao T, Nishio K, Itakura T. 2008. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Mol Cancer Ther 7:2768-78.
31. Gehris AL, Stringa E, Spina J, Desmond ME, Tuan RS, Bennett VD. 1997. The region encoded by the alternatively spliced exon IIIA in mesenchymal fibronectin appears essential for chondrogenesis at the level of cellular condensation. Dev Biol 190:191-205.
32. Gong SG, Mai S, Chung K, Wei K. 2009. Flrt2 and Flrt3 have overlapping and non-overlapping expression during craniofacial development. Gene Expr Patterns 9:497-502.
33. Govindraj P, West L, Smith S, Hassell JR. 2006. Modulation of FGF-2 binding to chondrocytes from the developing growth plate by perlecan. Matrix Biol 25:232-239.
34. Grashoff C, Aszodi A, Sakai T, Hunziker EB, Fassler R. 2003. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep 4:432-438.
35. Guo C, Degnin CR, Laederich MB, Lunstrum GP, Holden P, Bihlmaier J, Krakow D, Cho YJ, Horton WA. 2008. Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia. Cell Signal 20:1471-1477.
36. Haines BP, Wheldon LM, Summerbell D, Heath JK, Rigby PW. 2006. Regulated expression of FLRT genes implies a functional role in the regulation of FGF signalling during mouse development. Dev Biol 297:14-25.
37. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ. 2000. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 19:3309-3320.
38. Hart KC, Robertson SC, Donoghue DJ. 2001. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell 12:931-942.
39. Haub O, Goldfarb M. 1991. Expression of the fibroblast growth factor-5 gene in the mouse embryo. Development 112:397-406.
40. Haugsten EM, Malecki J, Bjorklund SM, Olsnes S, Wesche J. 2008. Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis. Mol Biol Cell 19:3390-3403.
41. Hinoi E, Bialek P, Chen YT, Rached MT, Groner Y, Behringer RR, Ornitz DM, Karsenty G. 2006. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev 20:2937-2942.
42. Horton WA. 2006. Skeletal Development. In: Unsicker K, Krieglstein K, editors. Cell signaling and growth factors in development. Weinheim: Wiley-VCH VerlagGmbH & Co. pp. 619-640.
43. Horton WA, Degnin CR. 2009. FGFs in endochondral skeletal development. Trends Endocrinol Metab 20:341-8.
44. Horton WA, Lunstrum GP. 2002. Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metab Disord 3:381-385.
45. Horton WA, Hall JG, Hecht JT. 2007. Achondroplasia. Lancet 370:162-172.
46. Hung IH, Yu K, Lavine KJ, Ornitz DM. 2007. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol 307:300-313.
47. Itoh N, Ornitz DM. 2008. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237:18-27.
48. Iwata T, Chen L, Li C, Ovchinnikov DA, Behringer RR, Francomano CA, Deng CX. 2000. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 9:1603-1613. (Pubitemid 30426997)
49. Jacob AL, Smith C, Partanen J, Ornitz DM. 2006. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296:315-328. (Pubitemid 44189342)
50. Kirsch T, Koyama E, Liu M, Golub EE, Pacifici M. 2002. Syndecan-3 is a selective regulator of chondrocyte proliferation. J Biol Chem 277:42171-42177. (Pubitemid 35257535)
51. Kiselyov VV, Skladchikova G, Hinsby AM, Jensen PH, Kulahin N, Soroka V, Pedersen N, Tsetlin V, Poulsen FM, Berezin V, Bock E. 2003. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 11:691-701.
52. Komada M. 2008. Controlling receptor downregulation by ubiquitination and deubiquitination. Curr Drug Discov Technol 5:78-84.
53. Komori T. 2005. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 95:445-453. (Pubitemid 41420175)
54. Kovalenko D, Yang X, Nadeau RJ, Harkins LK, Friesel R. 2003. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J Biol Chem 278:14087-14091. (Pubitemid 36799955)
55. Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE. 2007. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125-131. (Pubitemid 350056006)
56. Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, Wilcox WR. 2005. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 118:5089-5100. (Pubitemid 41672439)
57. Krejci P, Krakow D, Mekikian PB, Wilcox WR. 2007. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr Res 61:267-272.
58. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
59. Kronenberg HM, McMahon AP, Tabin CJ. 2009. Growth factors and chondrogenesis. In: Pourquie O, editor. The skeletal system. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press. pp. 171-203.
60. Kuro-o M. 2008. Endocrine FGFs and Klothos: Emerging concepts. Trends Endocrinol Metab 19:239-245.
61. Kurosu H, Kuro OM. 2008. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 299:72-78.
62. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M. 2006. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120-6123.
63. Lazarus JE, Hegde A, Andrade AC, Nilsson O, Baron J. 2007. Fibroblast growth factor expression in the postnatal growth plate. Bone 40:577-586. (Pubitemid 46187233)
64. Lew ED, Furdui CM, Anderson KS, Schlessinger J. 2009. The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations. Sci Signal 2:ra6.
65. Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX. 1999. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8:35-44. (Pubitemid 29039046)
66. Lin X, Buff EM, Perrimon N, Michelson AM. 1999. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126:3715-3723. (Pubitemid 29440471)
67. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869. (Pubitemid 34280109)
68. Liu Z, Lavine KJ, Hung IH, Ornitz DM. 2007. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol 302:80-91. (Pubitemid 46096925)
69. Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD. 2008. FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 19:2342-2350.
70. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. 2004. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131:1309-1318. (Pubitemid 38443885)
71. Mak KK, Kronenberg HM, Chuang PT, Mackem S, Yang Y. 2008. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 135:1947-1956. (Pubitemid 351943359)
72. Mariani FV, Ahn CP, Martin GR. 2008. Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. Nature 453:401-405.
73. Martin GR. 1998. The roles of FGFs in the early development of vertebrate limbs. Genes Dev 12:1571-1586.
74. Mason IJ, Fuller-Pace F, Smith R, Dickson C. 1994. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev 45:15-30. (Pubitemid 24051373)
75. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. 2002. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 3:439-449.
76. Minina E, Schneider S, Rosowski M, Lauster R, Vortkamp A. 2005. Expression of Fgf and Tgfbeta signaling related genes during embryonic endochondral ossification. Gene Expr Patterns 6:102-109. (Pubitemid 41819237)
77. Mohammadi M, Olsen SK, Ibrahimi OA. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16:107-137. (Pubitemid 40616111)
78. Mori S, Wu CY, Yamaji S, Saegusa J, Shi B, Ma Z, Kuwabara Y, Lam KS, Isseroff RR, Takada YK, Takada Y. 2008. Direct binding of integrin alphav-beta3 to FGF1 plays a role in FGF1 signaling. J Biol Chem 283:18066-18075.
79. Morris NP, Keene DR, Horton WA. 2002. Morphology and chemical composition of connective tissue: Cartilage. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley. pp. 41-66.
80. Mukherjee A, Dong SS, Clemens T, Alvarez J, Serra R. 2005. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. Mech Dev 122:557-571.
81. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B. 2004. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18:290-305.
82. Oberlender SA, Tuan RS. 1994. Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120:177-187.
83. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879.
84. Ornitz DM. 2005. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16:205-213.
85. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465.
86. Pandit SG, Govindraj P, Sasse J, Neame PJ, Hassell JR. 2002. The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs. Biochem J 361:231-241.
87. Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98:641-650.
88. Pourquie O. 2009. The skeletal system. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
89. Razzaque MS. 2009. The FGF23-Klotho axis: Endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5:611-9.
90. Rieckmann T, Zhuang L, Fluck CE, Trueb B. 2009. Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient. Biochim Biophys Acta 1792:112-121.
91. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366.
92. Savage MP, Fallon JF. 1995. FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros. Dev Dyn 202:343-353.
93. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211-225.
94. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6:743-750.
95. Schulz S. 2005. C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 26:1024-1034.
96. Settembre C, Arteaga-Solis E, McKee MD, de Pablo R, Al Awqati Q, Ballabio A, Karsenty G. 2008. Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev 22:2645-2650.
97. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568.
98. Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T. 2007. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18:2411-2418.
99. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B. 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23: 421-32.
100. Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schuler C, Erben RG, Lanske B. 2008. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4:e1000154.
101. Smith SM, West LA, Hassell JR. 2007. The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes. Arch Biochem Biophys 468:244-251.
102. Steinberg F, Zhuang L, Beyeler M, Kalin RE, Mullis PE, Brandli AW, Trueb B. 2010. The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos. J Biol Chem 285:2193-2202.
103. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086. (Pubitemid 29407348)
104. Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA, Fu XY. 1997. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292.
105. Su N, Du X, Chen L. 2008. FGF signaling: Its role in bone development and human skeleton diseases. Front Biosci 13:2842-2865. (Pubitemid 351589202)
106. Suyama K, Shapiro I, Guttman M, Hazan RB. 2002. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2:301-314. (Pubitemid 41043964)
107. Tavella S, Raffo P, Tacchetti C, Cancedda R, Castagnola P. 1994. N-CAM and N0cadherin expression during in vitro chondrogenesis. Exp Cell Res 215:354-362. (Pubitemid 24381086)
108. Tsang M, Dawid IB. 2004. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE pe17.
109. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J, Werb Z, Rosen SD. 2006. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: Effects on VEGF, FGF-1, and SDF-1. BMC Biochem 7:2.
110. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. 2006. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-4.
111. Wiedemann M, Trueb B. 2001. The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. Biochim Biophys Acta 1520:247-250.
112. Xu J, Lawshe A, MacArthur CA, Ornitz DM. 1999. Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech Dev 83:165-178.
113. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K. 2004. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPKdependent pathway. Nat Med 10:80-86.
114. Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, Miura M, Kanamoto N, Komatsu Y, Arai H, Nakao K. 2009. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150:3138-3144.
115. Yokote H, Fujita K, Jing X, Sawada T, Liang S, Yao L, Yan X, Zhang Y, Schlessinger J, Sakaguchi K. 2005. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc Natl Acad Sci USA 102:18866-18871.
116. Yoon BS, Pogue R, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM. 2006. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 133:4667-4678.
117. Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N. 2007. Mineralized tissue cells are a principal source of FGF23. Bone 40:1565-1573.
118. Yu K, Ornitz DM. 2007. The FGF ligand-receptor signaling system in chondrogenesis, osteogenesis and vascularization of the endochondral skeleton. Int Congress Ser 1302:67-78.
119. Yu K, Ornitz DM. 2008. FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development 135:483-491.
120. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074.
121. Zhang R, Murakami S, Coustry F, Wang Y, de Crombrugghe B. 2006. Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. Proc Natl Acad Sci USA 103:365-370.
122. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. 2006. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111-121.